Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I’m a performer! I do yoga every night and am generally active. No major health issues, just unhappy I can’t fit into old clothes and tired of my doctor bringing it up
What’s funny is that there are fantastic performers who are much, much larger than me, which further shows the disconnect between effort and result